1. P-101A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy. (2nd July 2019) Authors: Parisi, A; Cortellini, A; Roberto, M; Venditti, O; Santini, D; Dell'Aquila, E; Stellato, M; Marchetti, P; Occhipinti, M; Zoratto, F; Mazzuca, F; Tinari, N; De Tursi, M; Iezzi, L; Natoli, C; Ratti, M; Pizzo, C; Ghidini, M; Ficorella, C; Cannita, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-136Timed-flat infusion (TFI) 5-fluorouracil with irinotecan and oxaliplatin in pancreatic adenocarcinomas: A single institution experience with FIr/FOx regimen. (20th June 2018) Authors: Cortellini, A; Parisi, A; Cannita, K; Venditti, O; Pavese, F; D'Orazio, C; Lanfiuti Baldi, P; Vicentini, V; Vicentini, R; Porzio, G; Verna, L; Ficorella, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗